Products
About us
Experts
News
Koru Academy
Technologies
Contacts
en
en
es
Back
Home
News
News
All News
Articles
Announcements
From International Student to CEO - The Journey of a Young Russian Entrepreneur in Korea
Strong Q3 results, East Asia expansion, and upcoming IPO plans—discover the key highlights from Koru Pharma’s latest feature in Aju Business Daily.
Read more
Business Insider features Koru Pharma CEO Roman Vernidub on building in Korea as a foreign entrepreneur
Business Insider has featured Koru Pharma CEO Roman Vernidub in a profile on his journey as a foreign entrepreneur in Korea. The profile traces his path from student to founder and examines how cultural understanding and disciplined execution shape the way he works.
Read more
Pink Glow Clinical Efficacy Proven in Journal of Dermatology Research Publication
August 20, 2025 – A newly published case study of experts Dr. Vincent Wong and Dr. Abdulrahman Abdulbaky in the Journal of Dermatology Research has confirmed the clinical efficacy and safety of Pink Glow®, a glutathione-based mesotherapy solution, in the treatment of hyperpigmentation for darker skin types.
Read more
Koru Pharma Recognised by Inc. Magazine as a Global Leader in Aesthetic Biotech!
30 May 2025 - We’re thrilled to share some exciting news! Koru Pharma has been featured in Inc. magazine in a powerful new article spotlighting South Korea’s booming aesthetic tech scene!
Read more
Koru Pharma Recognised by CHOSUN DAILY
Koru Pharma, a leading exporter of medical and beauty products, has been featured in Joseon Ilbo
Read more
Koru Pharma in the spotlight of Chosun Ilbo
Highlighted by a leading Korean newspaper, Koru Pharma is redefining the beauty industry by exporting premium aesthetic products to over 100 countries. Discover the story behind our founder’s vision and commitment to innovation.
Read more
I Want The Beauty Industry To Associate "MADE IN KOREA" With Koru Pharma
Roman Vernidub, the CEO of Koru Pharma, plans to expand the manufacturing capacity of the company’s factory to 3 million syringes by the end of 2025 and reach a revenue of 70 billion won.
Read more
Koru Pharma CEO Roman Vernidub Shares Insights on Doing Business in East Asia in TNW Feature
Roman Vernidub, the CEO of Koru Pharma, was featured in a story by The Next Web (TNW). The article delves into the unique challenges and opportunities for startups and businesses entering the East Asian market. As a leader in the pharmaceutical and aesthetic medicine industries, Roman brought valuable insights and practical strategies to the conversation.
Read more